Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.57 USD
485.00 K USD
24.41 M USD
13.27 M
About Sensus Healthcare, Inc.
Sector
Industry
CEO
Joseph C. Sardano
Website
Headquarters
Boca Raton
Founded
2010
FIGI
BBG0074FZRZ0
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where SRTS is featured.
Frequently Asked Questions
The current price of SRTS is 8.89 USD — it has decreased by −0.45% in the past 24 hours. Watch Sensus Healthcare, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sensus Healthcare, Inc. stocks are traded under the ticker SRTS.
SRTS stock has risen by 20.14% compared to the previous week, the month change is a 32.69% rise, over the last year Sensus Healthcare, Inc. has showed a 319.34% increase.
We've gathered analysts' opinions on Sensus Healthcare, Inc. future price: according to them, SRTS price has a max estimate of 14.00 USD and a min estimate of 10.00 USD. Watch SRTS chart and read a more detailed Sensus Healthcare, Inc. stock forecast: see what analysts think of Sensus Healthcare, Inc. and suggest that you do with its stocks.
SRTS reached its all-time high on Aug 12, 2022 with the price of 15.25 USD, and its all-time low was 1.76 USD and was reached on May 14, 2020. View more price dynamics on SRTS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SRTS stock is 5.41% volatile and has beta coefficient of 1.74. Track Sensus Healthcare, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sensus Healthcare, Inc. there?
Today Sensus Healthcare, Inc. has the market capitalization of 146.36 M, it has increased by 16.88% over the last week.
Yes, you can track Sensus Healthcare, Inc. financials in yearly and quarterly reports right on TradingView.
Sensus Healthcare, Inc. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SRTS earnings for the last quarter are 0.07 USD per share, whereas the estimation was −0.01 USD resulting in a 800.00% surprise. The estimated earnings for the next quarter are 0.12 USD per share. See more details about Sensus Healthcare, Inc. earnings.
Sensus Healthcare, Inc. revenue for the last quarter amounts to 8.84 M USD, despite the estimated figure of 5.90 M USD. In the next quarter, revenue is expected to reach 10.77 M USD.
SRTS net income for the last quarter is 1.22 M USD, while the quarter before that showed 1.61 M USD of net income which accounts for −24.63% change. Track more Sensus Healthcare, Inc. financial stats to get the full picture.
No, SRTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 35.00 employees. See our rating of the largest employees — is Sensus Healthcare, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sensus Healthcare, Inc. EBITDA is 12.35 M USD, and current EBITDA margin is 0.12%. See more stats in Sensus Healthcare, Inc. financial statements.
Like other stocks, SRTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sensus Healthcare, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sensus Healthcare, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sensus Healthcare, Inc. stock shows the strong buy signal. See more of Sensus Healthcare, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.